Retina Biomarkers for Treatment Selection in DME - Top-Institutions - MDSpire

Retina Biomarkers for Treatment Selection in DME

  • By

  • Kailynn M. Barton, BS

  • Muhammad Abidi, BS

  • Rajiv M. Sastry, BA

  • John B. Miller, MD

  • May 1, 2026

  • 14 min

Share

Top Institutions in Ophthalmology

Brief introduction explaining scope and methodology.

  • #1

    Massachusetts Eye and Ear Infirmary
    Massachusetts Eye and Ear Infirmary

    Boston, MA

    Key Differentiators

    • Ophthalmology
    • Retina
    • Imaging Biomarkers

  • #2

    Bascom Palmer Eye Institute
    Bascom Palmer Eye Institute

    Miami, FL

    Key Differentiators

    • Ophthalmology
    • Retina
    • Clinical Trials

  • #3

    Wills Eye Hospital
    Wills Eye Hospital

    Philadelphia, PA

    Key Differentiators

    • Ophthalmology
    • Retina
    • Imaging

  • #4

    Johns Hopkins Wilmer Eye Institute
    Johns Hopkins Wilmer Eye Institute

    Baltimore, MD

    Key Differentiators

    • Ophthalmology
    • Retina
    • Translational Research

  • #5

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Ophthalmology
    • Retina
    • Imaging Research

Original Source(s)

Retina Biomarkers for Treatment Selection in DME

  • by Kailynn M. Barton, BS, Muhammad Abidi, BS, Rajiv M. Sastry, BA, John B. Miller, MD

  • May 1, 2026

Related Content

Retinal Imaging Model Aids CAD Detection

Fundus-based model showed moderate-to-good accuracy and improved performance when combined with clinical risk factors in a high-risk cohort

Advancing Retinal Imaging for Cardiovascular Risk Assessment

AACE 2026: AI moves from hype to reality in diabetes care

"Right now, AI is more of a copilot, but the long-term vision is something much closer to autopilot."